The estimated Net Worth of Steven L. Krill is at least $26.2 millier dollars as of 22 March 2017. Steven Krill owns over 14,125 units of Eagle Pharmaceuticals Inc stock worth over $26,203 and over the last 11 years Steven sold EGRX stock worth over $0.
Steven has made over 5 trades of the Eagle Pharmaceuticals Inc stock since 2015, according to the Form 4 filled with the SEC. Most recently Steven exercised 14,125 units of EGRX stock worth $137,295 on 22 March 2017.
The largest trade Steven's ever made was exercising 50,505 units of Eagle Pharmaceuticals Inc stock on 15 December 2016 worth over $1,204,039. On average, Steven trades about 8,236 units every 59 days since 2014. As of 22 March 2017 Steven still owns at least 7,025 units of Eagle Pharmaceuticals Inc stock.
You can see the complete history of Steven Krill stock trades at the bottom of the page.
Steven's mailing address filed with the SEC is C/O EAGLE PHARMACEUTICALS, INC., 50 TICE BLVD., SUITE 315, WOODCLIFF LAKE, NJ, 07677.
Over the last 11 years, insiders at Eagle Pharmaceuticals Inc have traded over $188,911,314 worth of Eagle Pharmaceuticals Inc stock and bought 1,029,065 units worth $16,655,732 . The most active insiders traders include Executive Capital Lphec Man..., Douglas L Braunstein et Investments Iv, L.P.Pro Que.... On average, Eagle Pharmaceuticals Inc executives and independent directors trade stock every 43 days with the average trade being worth of $193,721. The most recent stock trade was executed by Scott Tarriff on 1 November 2023, trading 21,619 units of EGRX stock currently worth $299,207.
Eagle Pharmaceuticals Inc executives and other stock owners filed with the SEC include: